Search results

JoinAditum Bio's Shayanne Ali and Medable's Andrew Mackinnon, as they discuss the most common issues with the paper-based consent process, and what to look for in a complete consent management solution in order to reduce quality issues while improving oversight.

In this blog, informed consent expert Camila Matheny discusses how to overcome common informed consent startup obstacles and streamline the ethics review process by adopting eICFs.

Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.

Gain tips on how to create Informed Consent Forms that better engage and educate trial participants.

With MarketsandMarkets projecting the global electronic Clinical Outcome Assessments (eCOA) solutions market to grow at compound annual growth rate (CAGR) of 16.1% each year until 2030, it’s clear the eCOA has made its impact within the clinical research landscape. Yet despite growing adoption, electronic Clinical Outcome Assessments (eCOA) are still surrounded by misconceptions that hinder their full potential. From concerns about patient usability to assumptions about cost and implementation timelines, these myths can create hesitation among sponsors and research teams alike.Thus, we’re here to cut through the noise and set the record straight with a summary of a recent webinar featuring speakers from Transcelerate and Medable.

Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.

Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.

This blog examines ways to improve this important communication process using clear language and the latest technology. Informed consent is a critical element of any clinical trial, as it starts the process that leads to a patient's participation in a trial. An informed consent form (ICF) is written by sponsors and delivered to patients to provide them with all the information they need about the study to make an informed decision around their participation.

With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.

Gain a quick overview of what top trends and topics dominated DIA 2023.

You asked, we answered. Find out how long it takes to plan for your first eConsent implementation in clinical trials.

Learn what impacts the new European Medicine Regulatory Network recommendations paper means to your clinical trial operations.

Gain a complete understanding of patient screening, including how best to screen patients in decentralized clinical trials.

Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.

On December 23, 2023, the FDA released guidance for the industry on how digital health technologies (DHTs) should be used in clinical trials. Below is a summary of each section contained above, to read through the FDA’s full text, click here.

More than an eCOA builder, Medable Studio’s simple point-and-click interface brings total control and transparency to the study launch process.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

How Medable and Lionbridge streamlined global study builds and cut translation timelines by 43% using new AI tools.

Use a consent experience that’s designed to meet the needs of patients, while educating and engaging them each step of the way. Read our free whitepaper to learn eConsent tips from patients themselves, and improve retention.

This Privacy Center is intended to help you identify the Medable privacy practices & Privacy Statements which apply to your use of Medable websites/applications.‍

This DBM App is the app and analytics platform for healthcare. Review the Medable DBM app Privacy Statement here.

Alex Burrington, Chief Technology Innovations Principal of Vertex, and Andrew Mckinnon, Vice President and General Manager of E-consent at Medable discuss common myths that continue to persist around eConsent, how to improve comprehension with patient-centric consent, and how to use a digital consent management tool to improve trial compliance, quality, and oversight.

Uncover the latest eConsent best practices from our Patient Caregiver Network in order to foster better-informed consent for your trials.

One of the most common questions we’re asked about digital informed consent/eConsent is: What does the ICF amendment or revision process look like within a digital platform and is this harder or easier than traditional paper-based approaches? Get the answer here.

Learn how to construct digital and paper informed consent forms that meet participants needs and instill trust and confidence in your clinical trial

Gain a complete understanding of electronic informed consent in decentralized and hybrid clinical trials, including tips on improving the process.

Recently, Medable worked with a leading market research consultant to identify the pains and processes that sponsors and CROs encounter when building trials. Of the many that were presented, one issue kept reappearing, the back and forth processes for building COAs. This feedback was instrumental in the development of Medable Studio, which was built to simplify the study build process, take eCOA off the critical path, and give sponsors and CROs total control over the trial build process.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Navigating the complexities of eCOA vendor selection can be tough. This comprehensive guide provides a step-by-step approach, covering everything from vendor evaluation to successful implementation, ensuring your clinical trial's success.

Learn why patient-centric ePRO instrument design is critical to driving study success, as it provides tips on how to make instruments more patient-centric, and offers resources for additional ePRO design guidance.

Electronic informed consent (eConsent) helps streamline the clinical trial process and reduce manual paper processing. Request your demo today.

Camila Matheny, EVP of DCT Offerings at Medable and Caroline Beaufour, PharmD, Ph.D., Innovation Lead, Clinical Development Support at Servier, dive into the intricacies of implementing electronic informed consent (eConsent) in clinical trials within the complex regulatory landscape of European countries.

Learn how clinical trial patient recruitment and patient engagement are intertwined, and how to improve them.

This blog showcases how clinical trial technologies that were initially categorized as “DCT (Decentralized clinical trials)" have now become a standard part of how clinical trials operate today.

This Privacy Center is intended to help you identify the Medable privacy practices & Privacy Statements which apply to your use of Medable websites/applications.‍

Introducing Medable Studio. More than a builder, Medable Studio delivers unprecedented control over the study creation and deployment process, freeing users from the roadblocks associated with study startup, such as protocol changes, vendor reviews, and more.

See how Medable's Patient Caregiver Network (PCN) improved post-seizure trial data for a CRO customer.

According to ClinicalTrials.gov, there are 3,046 multi-country trials being conducted this year. While many trials remain localized within a single country, there has been a definitive movement towards conducting trials in multiple countries, especially for larger, later-stage trials. This is driven by the positives that multi-country trials offer, like faster patient recruitment, lower costs in some regions, and the need for diverse patient populations.. However, behind the scenes, a critical bottleneck has been slowing many trials down. This bottleneck is the translation process that’s required to make trials work across multiple languages, locales, and regulatory bodies/organizations.